Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer
| BEAT Stock | USD 3.14 0.08 2.48% |
Slightly above 67% of Heartbeam's investor base is looking to short. The analysis of overall sentiment of trading Heartbeam stock suggests that many investors are alarmed at this time. Heartbeam's investing sentiment can be driven by a variety of factors including economic data, Heartbeam's earnings reports, geopolitical events, and overall market trends.
Heartbeam |
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced that Jon Hunt, PhD., has joined the company as its new Chief Commercial Officer , North America. In this role, Hunt will focus on business and sales strategies for the U.S. market to maximize growth, scale operations, and support technological innovations that help meet the growing demand for remote cardiac monitoring.
Read at finance.yahoo.com
 |
Heartbeam Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Heartbeam can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Heartbeam Fundamental Analysis
We analyze Heartbeam's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heartbeam using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heartbeam based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Heartbeam is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Heartbeam Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Heartbeam stock to make a market-neutral strategy. Peer analysis of Heartbeam could also be used in its relative valuation, which is a method of valuing Heartbeam by comparing valuation metrics with similar companies.
Peers
Heartbeam Related Equities
| LIFW | MSP Recovery | 103.77 | ||||
| EUDA | EUDA Health | 20.34 | ||||
| NUTX | Nutex Health | 0.92 | ||||
| MGRX | Mangoceuticals, Common | 0.40 | ||||
| BFRG | Bullfrog | 1.86 | ||||
| FOXO | FOXO Technologies | 2.00 | ||||
| HCTI | Healthcare Triangle | 19.49 |
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.